Decision Diagnostics Corp logo

Decision Diagnostics Corp

$ 0.00 0 (0%) 01:42 PM EST
P/E:
At Loss
P/B:
0
Market Cap:
$ 36.00K
Enterprise V:
$ 3.06M
Volume:
-
Avg Vol (2M):
57.07K
Volume:
-
Market Cap $:
36.00K
PE Ratio:
At Loss
Avg Vol (2-Month):
57.07K
Enterprise Value $:
3.06M
PB Ratio:
0
GF Score:
Year:
Embed
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
Decision Diagnostics Corp is a provider of prescription drugs, home testing products for the chronically ill, direct to patient diabetes programs, and a developer of revolutionary, cell phone centric, e-health products and technology. The company also provides blood glucose home testing test strips and exciting new concepts for blood testing monitors.

Financial Strength

Name Current Vs Industry Vs History
Cash-To-Debt 0.07
Equity-to-Asset -0.01
Debt-to-Equity -62.27
Debt-to-EBITDA -1.57
Piotroski F-Score N/A/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -22.7
Distress
Grey
Safe
Beneish M-Score -9.15
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
9-Day RSI 0.19
14-Day RSI 2.12
6-1 Month Momentum % -90.91
12-1 Month Momentum % -90

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.25
Quick Ratio 0.22
Cash Ratio 0.04
Days Inventory 34.07
Days Sales Outstanding 165.11
Days Payable 351.57

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -237.1

Profitability Rank

Name Current Vs Industry Vs History
Gross Margin % 23.37
Operating Margin % -88.97
Net Margin % -410.28
ROE % -4116.29
ROA % -157.01
ROIC % -25.22
ROC (Joel Greenblatt) % -252.57
ROCE % -450.61
Years of Profitability over Past 10-Year 2

GF Value Rank

Name Current Vs Industry Vs History
PS Ratio 0.02
EV-to-EBIT -1.49
EV-to-EBITDA -1.49
EV-to-Revenue 1.44
EV-to-FCF -2.85
Price-to-Median-PS-Value 0.01
Earnings Yield (Greenblatt) % -67.11

Financials

DECN's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with OTCPK:DECN

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Embed

Valuation Box

Year:
Embed

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 2.131
EPS (TTM) ($) -0.041
Beta -3.01
Volatility % 271.5
14-Day RSI 2.12
14-Day ATR ($) 0.000007
20-Day SMA ($) 0.0001
12-1 Month Momentum % -90
52-Week Range ($) 0.0001 - 0.0099
Shares Outstanding (Mil) 357.87

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 9999
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Decision Diagnostics Corp Filings

Document Form Filing Date
No Filing Data

Decision Diagnostics Corp Analysis

Share your research

Headlines

See More
No news.